300+ investors in your industry, stage, and region Get
Any industry
Community
Proptech
Biotech
Climate
Artificial Intelligence
Media (Entertainment)
Impact
FinTech
Marketplace
EdTech
Consumer
Agriculture (AgTech)
Web3
Clean Energy
B2B
Organic Food
Big Data
Video Games
Payments
Celebrity
Franchise
Mobile
Local
Social Network
Platforms
Crowdfunding
CleanTech
Film
Theatre
Life Science
Non Profit
Transportation
Gaming
Energy
Hardware
Health Care
Enterprise
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Publishing
Sporting Goods
Oil and Gas
Education
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Financial Services
Photography
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Blockchain
Legal
Android
Social Impact
Google
Construction
Sports
eSports
Enterprise Software
Email
Wellness
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Biotechnology
Medical Device
Wine and Spirits
Automotive
Social
InsurTech
SaaS
Software
Any country
Qatar
South Korea
Africa
Asia
LATAM
Europe
Oceania
Middle East
Ireland
Singapore
Indonesia
Spain
Saudi Arabia
Belarus
Belgium
Colombia
Denmark
Ecuador
Czech Republic
Estonia
Ghana
Ethiopia
Finland
Barbados
Italy
Jersey
Cayman Islands
Mali
Malaysia
Mauritius
Poland
Rwanda
Togo
Slovenia
San Marino
Tanzania
Thailand
Uruguay
Venezuela
Portugal
Azerbaijan
Namibia
Bolivia
Latvia
Cyprus
New Zealand
United States
Germany
Australia
India
United Kingdom
Canada
China
South Africa
Brazil
Japan
Sri Lanka
Vietnam
Argentina
Armenia
Austria
Bangladesh
Bahrain
Bulgaria
Bermuda
Chile
Cameroon
Switzerland
Belize
Costa Rica
Algeria
Georgia
Egypt
Hong Kong
Gibraltar
Faroe Islands
Greece
Croatia
France
Hungary
Kuwait
Israel
Lebanon
Cambodia
Kenya
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Morocco
Norway
Mexico
Panama
Malta
Peru
Philippines
Nicaragua
Pakistan
Russian Federation
Romania
Sweden
Serbia
Seychelles
Turkey
Puerto Rico
Sierra Leone
Senegal
Tunisia
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Taiwan
Ukraine
Zimbabwe
Bahamas
Guatemala
Iraq
Iceland
Nigeria
United Arab Emirates
Honduras
Isle of Man
Luxembourg
Oman
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 15 Life Science Startup Investors in Singapore (May 2026)

The most active venture capital funds and angel investors investing in Singapore Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Singapore Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
EDBI
VC Fund
3 United States, Singapore, China Series C, Series B, Series D Biotechnology, Software, Health Care $7M–$350M
Anzu Partners
VC Fund
3 United States, Canada, Spain Series A, Series B Biotechnology, Manufacturing, Software $872k–$22M
Eisai
VC Fund
2 Japan, United States, China Series A, Series C Biotechnology, Health Care, Medical
Lightstone Ventures
VC Fund
1 United States, Ireland, Singapore Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $5M–$95M
KB Financial Group
VC Fund
1 South Korea, India, Vietnam Series A, Series B, Seed Financial Services, Software, SaaS $1M–$107M
Amgen Ventures
VC Fund
1 United States, United Kingdom, Canada Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $3.2M–$59M
Hana Financial Investment
VC Fund
1 South Korea, Singapore, India Series A, Series B, Seed Information Technology, Biotechnology, Health Care $860k–$25M
M Capital Partners
VC Fund
1 France, United States, Canada Seed, Series A Health Care, Food and Beverage, Software $643k–$27M
KT investment
VC Fund
1 South Korea, United States, Singapore Series A, Series B, Seed Artificial Intelligence, Software, Information Technology $1.8M–$47M
K3 Ventures
VC Fund
1 Singapore, United States, Indonesia Series A, Seed Financial Services, FinTech, Software $874k–$100M
Openspace
VC Fund
1 Singapore, Indonesia, Philippines Series A, Series B, Series C E-Commerce, Financial Services, Information Technology $1.8M–$170M
Nestlé
VC Fund
1 United States, United Kingdom, Egypt Private Equity, Grant Food and Beverage, Health Care, Therapeutics $6k–$3.8B
Seeds Capital
VC Fund
1 Singapore, Hong Kong, United States Seed, Series A Software, Health Care, Biotechnology
Temasek Holdings
VC Fund
1 United States, China, India Series B, Series C, Series D Biotechnology, Health Care, Software $21M–$450M
SK Securities
VC Fund
1 South Korea, United States, Singapore Series A, Series B Therapeutics, Apps, Biotechnology $1.5M–$27M
Access all 29 investors in Singapore Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

EDBI
VC Fund · Singapore, Central Region, Singapore · 3 investments in Singapore Life Science startups, 9 in the past 12 months

EDBI is a premier Asian investor with headquarters in Singapore.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series C, Series B, Series D
  • Geography: United States, Singapore, China

Investor stats

  • Total investments: 151
  • Round size: Series B $10M–$200M; Series C $7M–$350M; Series D $21M–$226M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Thunes — Payment infrastructure for a connected world.
  • Endowus — Licensed by MAS. Grow all your money through intelligent investment portfolios built by experts, customised to your goals. Award-winning fee-only wealth platform.
  • Automera — Automera focuses on a novel therapeutic methods to develop drugs.
Show all investments...

Anzu Partners
VC Fund · Washington, District of Columbia, United States · 3 investments in Singapore Life Science startups, 10 in the past 12 months

Anzu Partners is an investment firm that focuses on industrial and life science technology companies with the potential to transform their industry. Anzu's portfolio support platform is dedicated to drive results beyond our initial investment and establish long-term relationships. We team with entrepreneurs to develop and commercializetechnological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. .Co-founders Whitney Haring-Smith, David Michael, and David Seldin launched the firm in 2014 in Washington, District of Columbia.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Software
  • Stage:Series A, Series B
  • Geography: United States, Canada, Spain

Investor stats

  • Total investments: 68
  • Round size: Series A $872k–$14M; Series B $5M–$22M
  • Lead/follow: 56% lead, 44% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Arduino — Arduino is an open-source electronics prototyping platform based on flexible, easy-to-use hardware and software. It's intended for artists, designers, hobbyists, and anyone interested in creating interactive objects or environments. Arduino created the worldwide trademark Genuino used as brand name outside the United States.
  • Aspinity — Aspinity offers neuromorphic all-analog integrated circuit technology that can replicate the functionality of digital signal processors. It reduces the system power requirements for always-on sensing applications.Their vision is that battery life does not have to stand in the way.It was founded in 2015 and headquartered in Pittsburgh,Pennsylvania.
  • South 8 Technologies — South 8 Technologies develops liquefied gas electrolyte chemistry for rechargeable lithium metal batteries and electrochemical capacitors.
Show all investments...

Eisai
VC Fund · Tokyo, Tokyo, Japan · 2 investments in Singapore Life Science startups

Eisai is a pharmaceutical company that researches and delivers medicines for patients.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series C
  • Geography: Japan, United States, China

Investor stats

  • Total investments: 13
  • Lead/follow: 31% lead, 69% follow

Portfolio highlights

  • Casma Therapeutics — Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomalstorage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.
  • Ractigen Therapeutics — Early-stage pharma company creating first-in-class therapies boosting expression of therapeutic genes in diseased cells using saRNA.
  • LIFENET INSURANCE COMPANY — LIFENET INSURANCE COMPANY offers a range of insurance underwriting and asset management solutions. Its insurance products include death, medical, and disability insurance. The company also provides health counselling services. LIFENET INSURANCE COMPANY was founded in October 2006.
Show all investments...

Lightstone Ventures
VC Fund · Menlo Park, California, United States · 1 investments in Singapore Life Science startups, 9 in the past 12 months

Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Ireland, Singapore

Investor stats

  • Total investments: 64
  • Round size: Series A $5M–$95M; Series B $7.5M–$90M; Series C $20M–$73M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Nimbus Therapeutics — Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company. Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinicaldevelopment. We are designing highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer and immune-inflammatory disorders.
  • Relievant Medsystems — Relievant's mission is to provide patients with low risk therapy that can alleviate their back pain.
  • Tagworks Pharmaceuticals — As pioneers of Click-to-Release technology, we are revolutionizing cancer treatment using in vivo click chemistry to increase the therapeutic window of powerful cancer therapies.
Show all investments...

KB Financial Group
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups

KB Financial Group is Korea’s leading financial institution with the largest customer base and the most extensive branch network in the country. With total assets exceeding US$342 billion, the Group wields a solid capital prowess and enjoys a strong brand loyalty. As of December 2012, the Group has ten domestic subsidiaries--banking, credit cards,securities, life insurance, asset management, real estate trust, venture capital, credit information, data system, and savings bank--and four overseas subsidiaries in Hong Kong, England, Cambodia, and China.KB Financial Group was established in September 2008 with extensive stock transfers from major subsidiary companies. The Group’s establishment was to better deal with such fundamental changes in the financial markets at home and abroad as the rapid globalization of financial service, a declining profitability of traditional banking operations, new industry regulations, and an increasing demand for comprehensive financial services.

Show more...

Investment focus

  • Industry: Financial Services, Software, SaaS
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, India, Vietnam

Investor stats

  • Total investments: 12
  • Round size: Series A $1M–$45M; Series B $7.6M–$107M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Nitra — Nitra offers expense management software that integrates with the banks to provide innovative loan products.
  • Wavebridge — Wavebridge is a top institutional digital asset company with traditional financial knowhows and crypto finance technology. The company was established in November 2018 to provide a comprehensive suite of investment solutions utilizing its data processing and AI technology.
  • BlockOdyssey — Best Enterprise Blockchain Enabler, Block Odyssey
Show all investments...

Amgen Ventures
VC Fund · San Francisco, California, United States · 1 investments in Singapore Life Science startups

Amgen Ventures is a venture capital investment arm of Amgen Inc. specializing in investments in early and later stage companies. The firm primarily invests in the biotechnology sector with a focus on discovering and developing human therapeutics with a focus on oncology, inflammation, hematology, nephrology, metabolic disorders, neuroscience, andcardiovascular therapeutics. In oncology and hematology it focuses on novel therapeutics including signal transduction, cell cycle, and apoptosis; hematopoiesis including anemia, neutropenia, and stem cell mobilization; and supportive care including mucositis and cachexia. In nephrology the firm focuses on renal failure and hyperparathyroidism. For inflammation the firm focuses on rheumatoid arthritis, psoriasis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, asthma and COPD, and osteoarthritis. Under cardiovascular, it focuses on acute coronary syndromes, dyslipidemia, and heart failure and under metabolic disorders it focuses on diabetes, metabolic syndrome, and osteoporosis. The focus on neuroscience included pain including neuropathic and inflammatory, alzheimer's disease, parkinson's disease, sleep disorder, cognition, and schizophrenia. In discovery research and technology the firm focuses on early-stage drug discovery collaborations, innovative chemical entity collections, diagnostics and biomarkers, novel antibody platforms, assay biologicals and devices, and target-focused structural biology and computational tools. It primarily invests in the North America, Europe, and the United Kingdom. The firm typically invests between $2 million and $3 million per transaction and may invest up to $10 million per company. It prefers to have an ownership stake of less than 15 % in its portfolio companies. Amgen Ventures was founded in 2004 and is based in San Francisco, California with additional offices in Seattle, Washington; Thousand Oaks, California; and Cambridge, Massachusetts.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 108
  • Round size: Series A $3.5M–$27M; Series B $14M–$59M; Series C $3.2M–$55M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: May invest from a new fund soon — last raise in 2012

Portfolio highlights

  • ImmunoScape — ImmuniScape discovers and develops novel TCR-based therapeutics against solid tumors
  • Inversago Pharma — Inversago Pharma is a preclinical-stage, biotech company specialized in the development of new therapies focusing on CB1 blockade, based on first-in-class, peripherally-acting, CB1 inverse agonists.
  • Casma Therapeutics — Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomalstorage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.
Show all investments...

Hana Financial Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups, 6 in the past 12 months

Hana Financial Investment Company Limited offers brokerage, securities dealing, underwriting, mutual funds, and online trading services

Show more...

Investment focus

  • Industry: Information Technology, Biotechnology, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, Singapore, India

Investor stats

  • Total investments: 87
  • Round size: Seed $860k–$2.5M; Series A $2.7M–$25M; Series B $3.8M–$24M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Trustay — Trustay is a real estate asset management company.
  • AIZEN Global — AIZEN is redesigning Digital Banking with CreditConnect, powered by our proprietary ABACUS AutoML platform specialized in the financial services industry. CreditConnect is an AI lending platform designed to bridge the gap between banks and data economy platforms, and automate key decision-making processes in accordance with the credit cycle. Thecompany has secured Series B round funding from a state-led fintech innovation fund (K-Growth) led by major Korean banks to roll out CreditConnect in Southeast Asia.We are also leading the digital transformation in the financial services industry using proprietary AutoML platform ABACUS, with successful use cases in underwriting, fraud detection, product development, claim analysis, and more.
  • Kuntian New Energy — Hebei Kuntian New Energy is a producer of anode materials for lithium-ion batteries.
Show all investments...

M Capital Partners
VC Fund · Toulouse, Midi-Pyrenees, France · 1 investments in Singapore Life Science startups

M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies.

Show more...

Investment focus

  • Industry: Health Care, Food and Beverage, Software
  • Stage:Seed, Series A
  • Geography: France, United States, Canada

Investor stats

  • Total investments: 97
  • Round size: Seed $643k–$5M; Series A $1.9M–$27M
  • Lead/follow: 64% lead, 36% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Ellona — Ellona develops environmental intelligence solutions-based devices for outdoor and indoor spaces. Its solutions help decision-makers improve their environments through the use of sensors capable of analyzing and monitoring both air quality and nuisances.
  • Olino — Olino is the insurance for tomorrow's SME. A digital service, a turnkey solution tailored to VSBs and SMEs, meeting all insurance needs.
  • Therapixel — Therapixel is one of the leading French software companies specializing in artificial intelligence applied to medical imaging.
Show all investments...

KT investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups, 9 in the past 12 months

kt investment is a new technology business finance company established in 2015. It is an investment company that represents KT Group .kt investment seeks to contribute to social contribution and maximize investment return through win-win cooperation with promising SMEs and venture companies .kt investment seeks to achieve long-term returns bylooking at the market from a global perspective and looking for value investment opportunities in the long term.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, Singapore

Investor stats

  • Total investments: 63
  • Round size: Seed $1.8M–$5M; Series A $1.8M–$47M; Series B $9.2M–$45M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • VCAT.AI — VCAT.AI is a business-to-business (B2B) subscription software (SaaS) based on AI technology. Create mass marketing creatives as video and banner images just with an product URL or TEXT.
  • cafe nono — Gathering together for quality discussions. Making your stories stand out. Join the community here and now!
  • Pion — Pion Corporation is an Martech focused video intelligence company. We provide “Vispot”, a video creation and ad-automation platform powered by AI.
Show all investments...

K3 Ventures
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups, 6 in the past 12 months

K3 Ventures provides venture capital for technology startups in various sectors such as finance, education, healthcare, food and agriculture and others. The firm is headed by Kuok Meng Xiong.

Show more...

Investment focus

  • Industry: Financial Services, FinTech, Software
  • Stage:Series A, Seed
  • Geography: Singapore, United States, Indonesia

Investor stats

  • Total investments: 85
  • Round size: Seed $874k–$20M; Series A $2M–$100M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Abound — Fintern is a lending startup looking to offer an AI-driven alternative to costly payday loans. It aims to expand access to low-cost personal credit by using the UK’s new Open Banking standard to analyze consumers’ historical bank statement data. Open Banking data allows us to build a granular view of customers’ financial circumstances, properlyunderstand their affordability, and place less reliance on credit reference agency scores.The company was founded in 2020 and is based in London, United Kingdom.
  • Sending.Me — SendingMe is Web3 native community chat software that engages, transacts, and compensates users.
  • Fable Food — Noun - A tasty story with animals as characters, not dishes . Open your eyes to the incredible taste, texture and goodness of Fable.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Openspace
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups, 11 in the past 12 months

Openspace Ventures is a leading venture capital firm finding and backing Southeast Asian companies creating a transformative impact where tech meets life.

Show more...

Investment focus

  • Industry: E-Commerce, Financial Services, Information Technology
  • Stage:Series A, Series B, Series C
  • Geography: Singapore, Indonesia, Philippines

Investor stats

  • Total investments: 96
  • Round size: Series A $1.8M–$16M; Series B $10M–$26M; Series C $3.5M–$170M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: Likely still investing — raised $25M in 2022

Portfolio highlights

  • Halodoc — Halodoc merupakan aplikasi kesehatan yang memberikan solusi kesehatan lengkap dan terpercaya untuk memenuhi kebutuhan kesehatan kamu dan keluarga.
  • Maka Motors — MAKA is dedicated to building the best electric motorcycles for Indonesian riders.
  • AMP — We make life simpler for merchants navigating the exponential growth of eCommerce with our suite of powerful software, global community, and educational resources.
Show all investments...

Nestlé
VC Fund · Vevey, Vaud, Switzerland · 1 investments in Singapore Life Science startups

Nestlé manufactures and sells food and beverage for several countries. It has generated more than CHF 90 billion in annual revenue. Its diverse product portfolio includes brands such as Nestlé, Nescafé, Perrier, Pure Life, and Purina. Nestlé also owns just over 23% of French cosmetics firm L'Oréal. It has a vast portfolio of global products,with 34 brands each achieving more than CHF 1 billion in sales annually and a geographic presence that spans 189 countries.

Show more...

Investment focus

  • Industry: Food and Beverage, Health Care, Therapeutics
  • Stage:Private Equity, Grant
  • Geography: United States, United Kingdom, Egypt

Investor stats

  • Total investments: 12
  • Round size: Grant $6k–$150k; Private Equity $130M–$3.8B
  • Lead/follow: 58% lead, 42% follow

Portfolio highlights

  • GuateValley — GuateValley interconnects local guides with travelers to live experiences in little-known destinations.
  • Sundial Foods — Sundial Foods utilizes a macro and microstructural engineering approach to create plant-based meat alternatives for conscious consumers.The company is passionate about making the affordable, accessible, and nutritional value of plant-based meats, made from ingredients that customers know and created using simple processes.It is headquartered inBerkeley, California in 2019.
  • Origin Materials — Origin is a new kind of chemical company, focused on the future of materials science.
Show all investments...

Seeds Capital
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups, 12 in the past 12 months

Seeds Capital is an investment arm of Enterprise Singapore that co-invests with independent investors in innovative startups. The firm was founded in 1992 and is headquartered in Central Region, Singapore.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: Singapore, Hong Kong, United States

Investor stats

  • Total investments: 96
  • Lead/follow: no public data

Portfolio highlights

  • Insectta — Insectta was founded in 2017 and produces materials from insects which can be applied across industries such as agrifood, pharmaceutical and electronics.
  • HydroLeap — Hydroleap reimagines the way the world looks at water. We provide chemical-free, high-performance & modularized technologies to replace conventional processes.
  • Zuno Carbon — Zuno provides end-to-end carbon management solutions that helps organizations measure, offset, and reduce emissions by integrating across your business value chain to collect activity data
Show all investments...

Temasek Holdings
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups, 29 in the past 12 months

Temasek is a global investment company headquartered in Singapore with a multinational staff of over 900 people. Our portfolio is valued at S$403 billion.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series C, Series D
  • Geography: United States, China, India

Investor stats

  • Total investments: 309
  • Round size: Series B $23M–$165M; Series C $21M–$350M; Series D $40M–$450M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Ola Electric — Ola Electric Mobility engages in the leasing of electric cars. It is working with vehicle and battery manufacturers, cities, driver-partners, and the mobility ecosystem to make electric mobility convenient, dependable, and affordable. Ankit Jain and Anand Shah founded Ola Electric Mobility on May 26, 2017. It has its headquarters in Bengaluru inIndia.
  • Metropolis — Metropolis unites technology and operations to make parking remarkable.
  • Electric Hydrogen — Electric Hydrogen designs and builds low-cost, high-efficiency green hydrogen systems to economically decarbonize industrial sectors like ammonia and steel
Show all investments...

SK Securities
VC Fund · Yongdungpo, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups

SK Securities is a South Korea-based financial service provider that specializes in the securities market. It primarily engaged in securities brokerage, dealing and underwriting businesses, covering stocks, futures, options, government bonds, corporate bonds, foreign exchanges, and financial derivative products. The company also involves in theinvestment banking business, which provides acquisition, project financing services, and wealth management services.SK Securities was founded in 1955.

Show more...

Investment focus

  • Industry: Therapeutics, Apps, Biotechnology
  • Stage:Series A, Series B
  • Geography: South Korea, United States, Singapore

Investor stats

  • Total investments: 13
  • Round size: Series A $1.5M–$27M; Series B $6.9M–$12M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Cerecin — Cerecin is a healthcare company that develops novel evidence-based therapeutics and products that aim to help people.We develop novel evidence-based therapeutics and products that aim to help millions of people. These solutions are designed to target conditions ranging from memory impairment to Alzheimer’s disease and other devastatingneurological diseases.
  • Easy Charger — Easy Charger provides EV infrastructure, electric two-wheeled vehicle battery station, solar power, and platform development services.
  • Travel Wallet — Travel Wallet is a foreign currency payment service that uses the Travel Wallet application. The travel Pay card is free of charge for overseas payments. The payments are overseas direct purchases and overseas payments without commission. The license for small overseas remittance businesses and electronic financial businesses by meeting variouscomputer facilities and all requirements. The platform agreement with banks.
Show all investments...

Life Science Investor funding in Singapore at a glance

Stats across 16 deals from 29 investors.

29
investors
in Singapore Life Science startups
16
deals
in Singapore Life Science startups
$20M
median round
in Singapore Life Science startups
52%
lead investors
lead at least one round
25%
Series A
most common funding stage
100/0
VC / Angel
share of investor count

Access all 29 investors in Singapore Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science Investors in Singapore investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 29 investors investing in Singapore Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists